Periostin as a biomarker of severity and mortality in COVID-19 patients
Our findings suggest that periostin level may help assessing disease severity and predicting mortality in COVID-19. Additional studies with expanded patient groups are needed.
Authors
- Hilmi Erdem Sümbül (ORCID: https://orcid.org/0000-0002-7192-0280)
- İsmail Yiğitdöl (ORCID: https://orcid.org/0000-0002-5959-5374)
- Erdinç Gülümsek (ORCID: https://orcid.org/0000-0003-0026-2396)
- Kubilay Akbal (ORCID: https://orcid.org/0000-0002-2263-5408)
- Okan Pirinci (ORCID: https://orcid.org/0000-0001-9699-1256)
- İbrahim Erdem (ORCID: https://orcid.org/0000-0003-4062-7900)
- Hüseyin Ali Öztürk (ORCID: https://orcid.org/0000-0001-5713-004X)
Institutions
- Ministry of Health (TR)
- State Hospital (GB)
- Sivas State Hospital (TR)
- University of Health Sciences Antigua (AG)
Publication Details
- Journal
- Expert Review of Clinical Immunology
- Published
- 2025-09-24
- DOI
- https://doi.org/10.1080/1744666x.2025.2566841
- Primary Topic
- COVID-19 Clinical Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00